These biotech leaders are the ones bringing home the most bacon. [© Mariusz Prusaczyk - Fotolia.com]
#5. Eli Lilly
John C. Lechleiter, Ph.D., Chairman, President, and CEO
2011 Compensation: $16,370,094
2010 Compensation: $16,504,545
% Change: -0.8%
#4. Amgen
Kevin W. Sharer, Chairman and CEO
2011 Compensation: $18,850,311
2010 Compensation: $21,138,133
% Change: -10.8%
#3. Abbott
Miles D. White, Chairman, CEO, and Director
2011 Compensation: $24,010,902
2010 Compensation: $25,564,283
% Change: -6.1%
#2. Pfizer
Ian Read, Chairman and CEO
2011 Compensation: $25,013,348
2010 Compensation: $17,396,112
% Change: 43.8%
#1. Johnson & Johnson
William C. Weldon, Chairman/CEO
2011 Compensation: $26,797,939
2010 Compensation: $28,720,491
% Change: -6.7%
Leave a comment by clicking the “Comments” icon below. We want to hear your thoughts!
1Converted to USD from CHF.
Total compensation includes salary, bonuses if any, stock awards, option awards, non-equity incentive plan compensation, annual charge to the pension fund plus non-qualified deferred compensation earnings, and all other forms of compensation. Figures were obtained from proxy statements and annual reports.